Manar et al. investigated the immuno-oncologic (IO) signature at the surgical tumor margin (TM) of OSCC undergoing malignant transformation and observed a significant upregulation of TDO2 in the tumor compared to TM, along with a significant downregulation of CD8 expression in tumor cells compared to TM. This evidence concerns the gene CD8A and neoplasm.